Viatris Inc (NASDAQ:VTRS)
| 13.10 Delayed Data As of 4:08pm ET |  -0.38 / -2.82%Today’s Change | 12.94 Today|||52-Week Range 18.86 | -30.10% Year-to-Date |
Latest VTRS News | Press Releases
Today’s Trading
| Previous close | 13.48 |
| Today’s open | 13.44 |
| Day’s range | 13.09 - 13.45 |
| Volume | 687,530 |
| Average volume (3 months) | 7,021,521 |
| Market cap | $16.9B |
Data as of 4:08pm ET, 10/27/2021
Growth & Valuation
| Earnings growth (last year) | -3,518.10% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +3.64% |
| Revenue growth (last year) | +3.83% |
| P/E ratio | NM |
| Price/Sales | 0.94 |
| Price/Book | 0.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGENRepligen Corp | -3.02 | -1.10% |
| INCYIncyte Corp | -1.56 | -2.34% |
| ---- | ||
| BHCValeant Pharmaceutic... | -0.77 | -2.70% |
Data as of 4:00pm ET, 10/27/2021
Financials
| Next reporting date | November 8, 2021 |
| EPS forecast (this quarter) | $0.88 |
| Annual revenue (last year) | $11.9B |
| Annual profit (last year) | -$669.9M |
| Net profit margin | -5.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Canonsburg, Pennsylvania |
Forecasts
